Keywords: inspire, suspends, bronchitis, drug, trial, pharmaceuticals, temporarily

Inspire suspends bronchitis drug trial

Article | 26 April 2001

Inspire Pharmaceuticals has temporarily suspended enrollment in a PhaseII trial of INS365 Respiratory for the treatment of chronic bronchitis in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genentech

Go to company listing